DJIA 18,030.21 6.04 0.03%
NASDAQ 4,773.47 8.05 0.17%
S&P 500 2,081.88 -0.29 -0.01%
market minute promo

Celldex Therapeutics (NASDAQ: CLDX)

17.08 -0.18 (-1.04%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CLDX $17.08 -1.04%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $17.45
Previous Close $17.26
Daily Range $16.96 - $17.66
52-Week Range $10.76 - $33.33
Market Cap $1.5B
P/E Ratio -14.03
Dividend (Yield) $0.00 (0.0%)
Volume 1,088,094
Average Daily Volume 3,707,941
Current FY EPS -$1.32

Sector

Healthcare

Industry

Drugs

Celldex Therapeutics (CLDX) Description

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease. Website: http://www.celldex.com/

News & Commentary

3 Beaten Down Stocks Ready to Bounce Back

Not all stocks had a great 2014. Here are three stocks that could be ready for a comeback.

4 Reasons I'm Adding Gilead To My Healthcare Holdings

Six Biotech and Technology Stocks With Strong Technical Set-Ups

Celldex's Glembatumumab Vedotin in Phase II for Melanoma - Analyst Blog

Today's Dead Cat Bounce Stock: Celldex Therapeutics (CLDX)

Here's The Last Biotech Breakout

Biotech Stock Mailbag: Northwest Bio, Celldex, Puma, MannKind

Celldex Therapeutics (CLDX) Stock Rises Today on High Volume

This Biotech Stock Is Ready To Run

Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst

Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog

See More CLDX News...

CLDX's Top Competitors

CLDX $17.08 (-1.04%)
Current stock: CLDX
AMGN $160.67 (2.00%)
Current stock: AMGN
GILD $91.15 (1.90%)
Current stock: GILD
BIIB $340.89 (1.53%)
Current stock: BIIB